Literature DB >> 19753840

[Mutations in the BRCA1 gene (185delAG and 5382insC) are not present in any of the 30 breast cancer patients analyzed from eastern Colombia].

María Carolina Sanabria1, Gerardo Muñioz, Clara Inés Vargas.   

Abstract

INTRODUCTION: Breast cancer is considered a worldwide public health problem, and, in Santander Province, Colombia, it is the first leading cause of morbidity and mortality by cancer in women. All cancers are considered genetic diseases, and mutations in BRCA (BReast CAncer) genes raises the risk for breast cancer by 60%-80%. The current study searched for the two most frequent BRCA1 mutations reported in the Breast Cancer Core Information database.
OBJECTIVE: The presence of specific mutations (185delAG, exon 2 and 5382insC, exon 20) was determined for the BRCA1 gene in women with familial/hereditary breast cancer.
MATERIALS AND METHODS: The sample included 30 female patients using the oncology services in Bucaramanga, eastern Colombia; an informed consent, a questionnaire and a blood sample were obtained from each. The molecular analysis was done with PCR-Mismatch, to detect the insertion or eliminatation of a restriction site, and enzymatic digestion methods (Hinfl or Ddel).
RESULTS: Two of the most frequent BRCA1 mutations in the international database were not found in the 30 patients studied.
CONCLUSION: Additional mutation screening techniques are necessary involving the entire BRCA1 gene, are necessary in order to better characterize the molecular epidemiology of breast cancer in Bucaramanga, Santander, Colombia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19753840

Source DB:  PubMed          Journal:  Biomedica        ISSN: 0120-4157            Impact factor:   0.935


  4 in total

1.  Genomic Disparities in Breast Cancer Among Latinas.

Authors:  Filipa Lynce; Kristi D Graves; Lina Jandorf; Charite Ricker; Eida Castro; Laura Moreno; Bianca Augusto; Laura Fejerman; Susan T Vadaparampil
Journal:  Cancer Control       Date:  2016-10       Impact factor: 3.302

2.  Prevalence and impact of founder mutations in hereditary breast cancer in Latin America.

Authors:  Patricia Ashton-Prolla; Fernando Regla Vargas
Journal:  Genet Mol Biol       Date:  2014-03       Impact factor: 1.771

3.  Multiplatform plasma metabolic and lipid fingerprinting of breast cancer: A pilot control-case study in Colombian Hispanic women.

Authors:  Mónica P Cala; Julian Aldana; Jessica Medina; Julián Sánchez; José Guio; Julien Wist; Roland J W Meesters
Journal:  PLoS One       Date:  2018-02-13       Impact factor: 3.240

4.  BRCA1 and BRCA2 mutations in a sample of breast and ovarian cancer families from the Colombian pacific.

Authors:  Laura Cifuentes-C; Ana Lucia Rivera-Herrera; Guillermo Barreto
Journal:  Colomb Med (Cali)       Date:  2019-09-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.